BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Stem cell
,
Hematopoietic cell
,
Doxorubicin
,
rs2300478
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
positive regulation of receptor recycling
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Mucopolysaccharidosis
Pyloric ulcer
Disease due to Orthopoxvirus
Bacterial pneumonia
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
tivozanib
CGP 60474
SB939 compound
PHA 793887
MP470
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CAMK1
PHEX
NR5A1
AGL
TRIB1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
Normal and Mucopolysaccharidosis VII ascending aorta gene expression
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for positive regulation of receptor recycling
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
Multi-Drug Desensitization Protocol for Heart Transplant Candidates
FGF19 in Obstructive Cholestasis: "Unveil the Signal"
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ